Medtronic PLC (MDT)
80.38
-0.91
(-1.12%)
USD |
NYSE |
Apr 24, 16:00
80.81
+0.43
(+0.53%)
Pre-Market: 20:00
Medtronic Cash from Financing (Quarterly): -1.50B for Jan. 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| January 31, 2024 | -1.50B |
| October 31, 2023 | -90.00M |
| July 31, 2023 | -501.00M |
| April 30, 2023 | -4.89B |
| January 31, 2023 | -2.134B |
| October 31, 2022 | 3.014B |
| July 31, 2022 | -950.00M |
| April 30, 2022 | -1.949B |
| January 31, 2022 | -1.177B |
| October 31, 2021 | -1.155B |
| July 31, 2021 | -1.055B |
| April 30, 2021 | -5.129B |
| January 31, 2021 | -998.00M |
| October 31, 2020 | 32.00M |
| July 31, 2020 | 1.959B |
| April 30, 2020 | -1.31B |
| January 31, 2020 | -873.00M |
| October 31, 2019 | -1.741B |
| July 31, 2019 | -274.00M |
| April 30, 2019 | -860.00M |
| January 31, 2019 | -1.268B |
| October 31, 2018 | -1.73B |
| July 31, 2018 | -1.573B |
| April 30, 2018 | -3.828B |
| January 31, 2018 | -849.00M |
| Date | Value |
|---|---|
| October 31, 2017 | -6.136B |
| July 31, 2017 | -1.141B |
| April 30, 2017 | 687.00M |
| January 31, 2017 | -1.319B |
| October 31, 2016 | -1.491B |
| July 31, 2016 | -1.16B |
| April 30, 2016 | -5.866B |
| January 31, 2016 | -1.152B |
| October 31, 2015 | -781.00M |
| July 31, 2015 | -1.744B |
| April 30, 2015 | 1.151B |
| January 31, 2015 | 14.92B |
| October 31, 2014 | 228.00M |
| July 31, 2014 | -355.00M |
| April 30, 2014 | -717.00M |
| January 31, 2014 | -142.00M |
| October 31, 2013 | 363.00M |
| July 31, 2013 | -422.00M |
| April 30, 2013 | -952.00M |
| January 31, 2013 | -387.00M |
| October 31, 2012 | -119.00M |
| July 31, 2012 | -643.00M |
| April 30, 2012 | -536.00M |
| January 31, 2012 | -502.00M |
| October 31, 2011 | -347.00M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-5.129B
Minimum
Apr 2021
3.014B
Maximum
Oct 2022
-1.079B
Average
-1.026B
Median
Cash from Financing (Quarterly) Benchmarks
| Abbott Laboratories | -2.052B |
| Boston Scientific Corp | 15.00M |
| Stryker Corp | -286.00M |
| Axonics Inc | 0.578M |
| Conmed Corp | -58.77M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 2.474B |
| Cash from Investing (Quarterly) | -707.00M |
| Free Cash Flow | 4.931B |
| Free Cash Flow Per Share (Quarterly) | 1.598 |
| Free Cash Flow to Equity (Quarterly) | 2.026B |
| Free Cash Flow to Firm (Quarterly) | 2.299B |
| Free Cash Flow Yield | 4.60% |